{
    "code": "56027906",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56027906",
    "time": "2020-12-04 05:14:00",
    "許可證字號": "衛部醫器輸字第027906號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4354",
    "有效日期": "114\/11\/17",
    "發證日期": "104\/11\/17",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602790609",
    "中文品名": "英尤凱吸入性過敏原篩檢試劑",
    "英文品名": "ImmunoCAP Phadiatop",
    "效能": "本產品以定性和半定量方法來分級人類血清或血漿中吸入性過敏原的特異性IgE。其目的為臨床實驗室體外診斷用，配合其它臨床證據作為輔助性IgE過敏性疾病的臨床診斷方法。本產品搭配法迪亞100、法迪亞250或法迪亞1000儀器進行檢測。",
    "醫器規格": "14-4405-41。\r\n規格(有效期間)變更為：24個月。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5510免疫球蛋白A，G，M，D及E免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620110P095  台灣法迪亞股份有限公司",
    "申請商地址": "台北市內湖區洲子街85號6樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "MSE0039000  PHADIA AB",
            "製造廠廠址": "Rapsgatan 7P, P.O. Box 6460, 751 37 Uppsala, Sweden",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560279060003-106-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027906&Seq=002&Type=9"
        },
        {
            "title": "560279060001-104-12-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027906&Seq=001&Type=9"
        },
        {
            "title": "560279060003-106-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027906&Seq=002&Type=8"
        },
        {
            "title": "560279060002-104-12-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027906&Seq=001&Type=8"
        }
    ]
}